Skip to main content
Elos Medtech logo

Elos Medtech — Investor Relations & Filings

Ticker · ELOS ISIN · SE0000120776 LEI · 529900I5MSNU451FL670 ST Manufacturing
Open in API
Filings indexed 331 across all filing types
Latest filing 2018-04-03 Annual Report
Country SE Sweden
Listing ST ELOS

About Elos Medtech

http://elosmedtech.com

Elos Medtech is a contract development and manufacturing organization (CDMO) specializing in the medical device sector. The company partners with medical technology firms, providing comprehensive services that span the entire product lifecycle, from research and development to manufacturing and commercialization. Its core focus areas include dental, orthopedics, and advanced surgical products. Elos Medtech offers a range of capabilities, including precision manufacturing, polymer injection molding, process optimization, packaging, and regulatory support. The company operates through specialized business units that collaborate to provide clients with tailored solutions, aiming to streamline operations, reduce complexity, and accelerate innovation in the medical device field.

Recent filings

Filing Released Lang Actions
Annual Report 2017
Annual Report Classification · 100% confidence The document is titled 'ÅRSREDOVISNING 2017' (Annual Report 2017) for Elos Medtech. It contains a comprehensive overview of the company's performance, including a table of contents, management review (VD har ordet), financial statements (resultaträkning, balansräkning, kassaflödesanalys), notes, and an audit report (Revisionsberättelse). It is a full-year financial report, not an announcement or a summary, and exceeds the length requirements for a standard annual report. FY 2017
2018-04-03 Swedish
Elos Medtech – Årsredovisning och Hållbarhetsredovisning för 2017 publicerad
Report Publication Announcement Classification · 98% confidence The document text is a short announcement (1500 chars) titled 'Elos Medtech – Årsredovisning och Hållbarhetsredovisning för 2017 publicerad' (Annual Report and Sustainability Report for 2017 published). It explicitly states that the Annual Report (Årsredovisning) and the Sustainability Report (Hållbarhetsredovisning) are being published today on their website and directs readers there. According to Rule #2 (The 'MENU VS MEAL' Rule), a short document announcing the publication of a report, rather than containing the full report content, should be classified as a Report Publication Announcement (RPA). Although it mentions the content of an Annual Report (10-K) and an ESG report (SR), the document itself is the announcement of their release.
2018-04-03 Swedish
Kallelse till årsstämma i Elos Medtech AB (publ)
AGM Information Classification · 99% confidence The document is titled "Kallelse till årsstämma i Elos Medtech AB (publ)" which translates to 'Notice of Annual General Meeting in Elos Medtech AB (publ)'. It details the date, location, registration process, agenda items (including election of board members, auditor, remuneration guidelines, and dividend proposal), and refers to the Annual General Meeting (Årsstämma). This content is characteristic of a formal notice calling shareholders to the AGM, which aligns directly with the definition for AGM Information (AGM-R). Although it contains elements that might be found in other reports (like remuneration details or financial context), the primary purpose and structure are that of the meeting notice itself.
2018-03-22 Swedish
Elos Medtech AB offentliggör emissionsprospekt
Capital/Financing Update Classification · 98% confidence The document is titled "Elos Medtech AB offentliggör emissionsprospekt" (Elos Medtech AB publishes offering prospectus) and details a rights issue (nyemission med företrädesrätt) of 104.9 million SEK. It mentions the prospectus has been approved by the Swedish Financial Supervisory Authority (Finansinspektionen) and provides details on subscription periods, share prices, and investor meetings. This clearly relates to a corporate action involving fundraising and capital structure changes. The most appropriate category is 'Capital/Financing Update' (CAP). Although it mentions a prospectus, the core content is the announcement and summary of the financing event itself, not just the announcement of the report's publication (RPA) or a general regulatory filing (RNS).
2018-02-27 Swedish
Elos Medtech offentliggörföreträdesemission om 104,9 MSEK för genomförande av investeringar i produktionskapacitet
Capital/Financing Update Classification · 99% confidence The document is a press release announcing a rights issue (företrädesemission) of 104.9 MSEK to fund investments in production capacity. It details the terms of the offering, including the subscription price, record date, subscription period, and indications of support from major shareholders. This type of announcement, concerning fundraising, financing activities, and capital structure changes (specifically issuing new shares via a rights issue), directly corresponds to the definition of 'Capital/Financing Update'. The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI). Therefore, the appropriate code is CAP.
2018-02-19 Swedish
Earnings Release 2017
Earnings Release Classification · 95% confidence The document provides detailed financial results for the full year (Januari-December) and the fourth quarter (oktober-december) of 2017, including key metrics like Nettoomsättning (Net Sales), Rörelseresultat (Operating Result), Resultat efter skatt (Net Income), and Earnings Per Share. It also discusses business segment performance and future plans, specifically mentioning a proposed rights issue (företrädesemission) to fund capacity expansion. The comprehensive nature of the financial data covering a full fiscal year strongly indicates an Annual Report or a similar comprehensive period report. Since it covers the full year and contains detailed financial statements/tables, it aligns best with the scope of a comprehensive annual report, although it is not explicitly labeled '10-K'. Given the options, and the fact that it is a detailed report covering the full year's performance, it is classified as an Annual Report (AR) or potentially an Interim Report (IR) if it were only half-year, but since it is full-year data, AR is the closest fit among the provided codes for a comprehensive annual financial disclosure, even if it's a local equivalent rather than a formal SEC 10-K. However, looking closely at the definitions, '10-K' is specifically for the official yearly report. Since this appears to be a detailed annual financial report (likely a Swedish equivalent of an Annual Report), and 'AR' is defined as 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)', this document, being the full annual performance review, is best classified as the closest equivalent to a full Annual Report, which is '10-K' in this context, or if we strictly adhere to the provided definitions where '10-K' is the only option for a full yearly report, we select that. If the document were shorter and only an announcement, RPA would be chosen. Since it contains the full data, it is the report itself. Given the context of global financial databases, '10-K' is often used as the placeholder for the primary annual filing, even if the source is non-US. If we must choose between AR and 10-K, the content is a full annual report, making 10-K the most appropriate category for a comprehensive yearly filing. FY 2017
2018-02-19 Swedish

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.